RIFAMYCIN SV

RIFAMYCIN SV

6998-60-3

C₃₇H₄₇ N O₁₂

rifomycin sv (6ci) ; rifampin sv ; rifamycin ; 2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2h)-dione,21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-,(2s,12z,14e,16s,17s,18r,19r,20r,21s,22r,23s,24e)- ; rifamycin s-na ; rifomycin ; rifamycin (9ci) ; rifamicinesv ; (2s,12z,14e,16s,17s,18r,19r,20r,21s,22r,23s,24e)-21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2h)-dione ; nsc 133100 ; rifocin ; 2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2h)-dione,5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-,21-acetate (8ci) ; rifamicine sv ; rifamycin sv ; rifogal ; [2s-(2r*,12z,14e,16r*,17r*,18s*,19s*,20s*,21r*,22s*,23r*,24e)]-21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2h)-dione ; rifocyn ; riphogal ; rifaximin ep impurity c ; 17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-21-acetate